MRSA contamination from the patient's environment, should lower hospital-acquired MRSA rates and associated healthcare costs. This study evaluates a hospital-wide environmental and patient cleaning protocol on MRSA rates and the associated infection cost avoidance in a single acute care hospital.
Methods
A retrospective, pre-post interventional study design was used to review the hospital's infection control database for all hospital acquired invasive MRSA infections from 1 January 2005 to 30 September 2009 at one acute care teaching hospital in California in the United States of America. National Health Safety Network (NHSN) and Centers for Disease Control and Prevention (CDC) criteria were used in determining invasive MRSA infections which consists of the following: isolation of MRSA from a normally sterile site and the MRSA culture was obtained after 48 h of hospitalisation or any time after a surgical procedure (CDC, 2016) . We compared the rate of MRSA infection per 1000 patient days (PD) before and after implementation of the hospital-wide environmental and patient cleaning protocol on 1 January 2006 and based our cost-benefit analysis on these rates. Prior to 1 January 2006, the following community standard infection control practices were in place: (1) environmental services personnel (EVS) supervisor trained the EVS personnel to clean the hospital (patients' rooms, floors and bathrooms) on a daily basis using Environmental Protection Agency registered disinfectant products (3M Neutral Quat, 3M, St Paul, MN, USA, and Clorox Bleach, Clorox, Oakland, CA, USA). This was done without any specific decontamination training and mostly to remove dirt from the hospital environment; (2) nursing and ancillary staff washed patients with soap and water only as needed; (3) hand washing/sanitiser use was an integral part of infection control including easy access to soap/water/ hand sanitiser and yearly training on the importance of hand hygiene; (4) isolation protocols were used for patients with a history of a multi-drug resistant organisms (MDRO) (both colonised and infected, e.g. history of MRSA). All patients with transmissible diseases were isolated as per CDC guidelines (Seigel et al., 2007) ; (5) compliance was monitored by the infection control department and retraining on isolation procedures and hand hygiene was performed as needed. After 1 January 2006 a hospital-wide environmental and patient cleaning protocol (Steiros Algorithm ® , Steiros, Long Beach, CA, USA) was implemented. The process is a multi-tiered, whole hospital environmental and patient cleaning method for the hospital and patient environment using embedded products as previously described (Everett et al., 2014) . This bundled process was implemented in 2006 by two of the authors as part of their infection control practitioner roles at this hospital facility following recommendations of the California Department of Health Services Healthcare Associated Infection Advisory Working Group for infection prevention in hospitals in the state of California (Chavez et al., 2005) . This bundle had been developed by one author and utilised over years at different healthcare facilities with success. Ethical approval was sought and approval given by the hospital's Medical Executive Committee and Chief Executive Officer. The interventions are summarised in Table 1 and include the following: (1) EVS were trained quarterly with a 1-h presentation given by one of the authors to do daily cleaning of very specific high touch areas (e.g. doorknobs, hand rails, tables, remote controls, etc.) throughout the facility using embedded quaternary ammonium cleaning products (Steiros Hard Surface Wipes, Germcure, Houma, LA, USA); (2) nursing staff were trained yearly how to use a skin sanitiser (active ingredient 0.13% benzalkonium chloride) to wash patients on a daily basis until discharge from the hospital. The United States Food and Drug Administration (FDA) registered skin sanitiser is a 'wipe on and leave on until dry' product and was utilised based on previous experience with its efficacy, ease of use and low allergic reaction rate as no CDC patient washing product guidelines were available during the study period; (3) hand washing/sanitation was re-emphasised as an integral part of infection control including quarterly training on hand hygiene and monthly unit specific reporting on hand hygiene compliance rates with retraining as necessary; (4) a yearly 1-h educational meeting was attended by all hospital employees involved in patient care which introduced the infection control process and emphasised the importance of cleaning all equipment including nursing stations, transport beds, monitors and other common areas; (5) isolation protocols were held to strict CDC mandatory isolation guidelines only (e.g. actively draining culture positive wounds or active tuberculosis) and not for history of disease only (e.g. history of MRSA) (Seigel et al., 2007) ; (6) awake patients signed daily room EVS cleaning checklist to ensure compliance; and (7) compliance was monitored on a systematic and periodic basis by the infection control department by: (i) performing unit specific swab cultures of the high touch areas to verify cleaning and quarterly retraining as needed, (ii) regular monitoring of electronic and patient signed checklists to verify daily room and patient cleaning, and (iii) spot checks by the infection control department of all units where infections occurred with retraining performed as needed. No admission MRSA screening cultures were performed during the study period.
All data were collected monthly via the Hospital Infection Control and Safety Department database using standard surveillance for reporting to the CDC and NHSN using criteria in determining invasive MRSA infections which consists of the following: isolation of MRSA from a normally sterile site and the MRSA culture was obtained after 48 h of hospitalisation or after a surgical procedure (CDC, 2016) . Infections were identified by analysing current procedure terminology (CPT) codes and International Classification of Diseases-9 coding. This standardised MRSA surveillance program was used throughout the study period. During the study period, the hospital infection control database tracked infection rates per 1000 patient days. Daily checklists for compliance of both EVS room cleaning and patient washing were reviewed and the percent compliance was calculated. The studied time frame was used because a modification to the standardised surveillance program and reporting was made in October of 2009 and would have confounded the comparison rates. Also, prior to 2005, MRSA-specific infection data were not available in the infection database which limited our pre-intervention data to 1 year.
For the cost analysis, our objective was to compare hospital-acquired MRSA infection healthcare costs 12 months before and 45 months after institution of the protocol to determine if the protocol avoided overall healthcare costs related to hospital-acquired MRSA infections. The hospital direct material and manpower costs before and after implementation of the protocol were not available for collection for this analysis. However, a previously published costbenefit analysis (Everett et al., 2014) showed that implementation costs of this protocol in a similar community hospital were cost-neutral. The costs associated with the products, cleaning and training were offset by the reduction in isolation costs. Based on this previous research we assumed the implementation of the protocol to be cost-neutral in the cost analysis. Previously published costs associated with hospital-acquired MRSA infections of $6916 dollars per infection were used for the infection cost estimates (Scott, 2009; Tubbicke et al., 2012) . We multiplied the number of infections in 2005 by $6916 dollars and divided that by 12 months and used this as a pre-protocol cost per month. We then multiplied the number of infections of years 2006-2009 (45 months) by $6916 dollars and subtracted this number from the pre-protocol cost per month times 45 months to get the total cost avoidance.
A portion of the MRSA infection reduction seen in our study was likely associated with an overall decline in MRSA rates. National and California specific studies show that invasive MRSA rates gradually decreased over the study period. The CDC reported a national downward trend in invasive MRSA rates between 2005 and 2011 of 54% without year-specific data (Dantes et al., 2013 (Tehrani et al., 2013) . In 2005-2009 the hospital-acquired MRSA rates in California fell from 1.4 to 1.2 per 1000 admissions, a decrease of 14%. For this reason, we multiplied the total cost avoidance by four different estimate models (0%, 14%, 37%, 54%) based on MRSA trends from the state of California and the USA Dantes et al., 2013; Tehrani et al., 2013) to get the best and worst case total cost avoidance scenarios. No patient specific data were obtained or recorded and therefore review and approval by the Institutional Review Board was not necessary. No additional infection control processes were introduced or changed during the study period. The two tailed Pearson chi-square with a Yates' correction was used to determine the P value.
Results
The results are summarised in Figure 1 Table 2 summarises the healthcare MRSA infection cost avoidance due to the avoidance of 239.32 MRSA infections using four different models to estimate MRSA reduction trends from the state of California and the USA during that time period. Avoided overall healthcare infection costs ranged from $1,655,143 to $3,310,286 over a 45-month period. In 2006-2009, the compliance for daily patient washing and EVS checklist completion was 94%.
Discussion
This hospital-wide environmental and patient cleaning protocol appears to be associated with a reduction in hospitalacquired MRSA rates. We believe that the ease of implementation, the daily cleaning of very specific high touch areas and patients, universal decolonisation with a benzalkonium chloride sanitiser and targeted isolation is what separates this hospital-wide environmental and patient cleaning protocol from other bundles. In this bundle, decontamination of the environment along with universal decolonisation allowed for minimal isolation which improves patient satisfaction (Abad et al., 2010; Masse et al., 2013; Mehrotra et al., 2013) . Also, the efficacy of isolation precautions in protecting patients from MRSA has recently come into question Lopez-Alcalde et al., 2015) . For this reason, we believe with this process isolation can be minimised with good results. In addition, from an overall healthcare perspective, this protocol appears to be associated with the reduced hospital-acquired MRSA costs.
There are many limitations to our study. The non-randomised study design limited to only one hospital and a retrospective control, limits our ability to link causation of the decline in MRSA infection rate to the specific changes that were implemented (Harris et al., 2005) . The study type was chosen due to administrative and financial constraints. Multiple factors were changed as part of the intervention including environmental cleaning, patient washing, personnel training and a large reduction in numbers of patients under isolation precautions. Use of a prospective randomised protocol would better demonstrate causation and the most efficacious factors in the protocols (environmental cleaning or other factors including patient washing, isolation reduction or hand hygiene). Future research on this topic would be beneficial. In addition, without patient-specific data, bias may be introduced depending on the health of the population and underlying MRSA colonisation rate. In this medium-sized community hospital, we had a stable population base over time making this type of bias less likely. Due to limitations of our infection control database, MRSA-specific data from years prior to 2005 were not available. An outbreak occurring in the year 2005 could bias the data. However, the quarterly data from 2005 are evenly distributed throughout the year making a focal outbreak less likely.
Additionally, the CDC and California Department of Public Health made efforts to reduce the rates of invasive MRSA during the study period with success. National and California specific studies show that invasive MRSA rates were gradually decreasing over the study period. (CDC, 2015; Dantes et al., 2013; Tehrani et al., 2013) . We presented a range of downward assumptions of MRSA rates presenting the best and worst case scenario for cost avoidance caused by the national and regional MRSA rate trends, especially given the lower decreases reported in California. Therefore, to avoid overestimating the cost avoidance, our cost analysis used a 0-54% reduction in MRSA rates to give a range of possible cost avoidance that may be achieved with this protocol (Drummond et al., 2005) . Multiple previous studies had suggested that environmental cleaning reduces MRSA rates by reducing contamination (Dancer et al., 2009; Everett et al., 2014; Goodman et al., 2008; Hayden et al., 2006) . Our data further support an association between environmental contamination and transmission of MRSA and that a protocol that includes hospital-wide environmental cleaning protocol appears to contribute to protecting patients. In addition, this particular protocol has been shown elsewhere to decrease all hospitalacquired infection (HAI) rates. When used in a large acute care teaching hospital, Everett et al. showed that this hospital-wide environmental and patient cleaning protocol decreased all HAI rates 64% overall, including a reduction of MRSA infection rates by 63%, and reduced associated hospital costs (Everett et al., 2014) . In addition, Watson et al. showed that this protocol reduced SSI rates to zero over a 2-year period (Watson et al., 2012) .
Conclusion
In summary, institution of a hospital-wide environmental and patient cleaning protocol comprising enhanced cleaning of the patient environment, daily patient cleaning with benzalkonium chloride sanitiser and targeted use of isolation appears to be associated with a reduction in the rate of hospital-acquired MRSA infection and therefore a reduction in associated healthcare costs.
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